F Di Silverio|F Sciarra - JoVE Visualize

Showing results (91-100 of 150) with videos related to

Pageof 15

Sort By:

Journal of Andrology|March 1, 1996

Ultrastructural and immunohistochemical characterization of the tunica albuginea in Peyronie's disease and veno-occlusive dysfunctionV Gentile, A Modesti, G La Pera, et al.

European Urology|January 1, 1997

Effects of short-term treatment with the alpha 1-blocker alfuzosin on urodynamic pressure/flow parameters in patients with benign prostatic hyperplasiaG Martorana, C Giberti, F Di Silverio, et al.

Minerva Medica|April 7, 1983

[Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension]C Tosti-Croce, R Mantellini, P Fanti, et al.

The Journal of Clinical Endocrinology and Metabolism|August 1, 1990

Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian diseaseV Toscano, R Balducci, P Bianchi, et al.

Clinical Endocrinology|May 1, 1978

24 hour profile of 18-hydroxy-11-deoxycorticosterone in normal supine man: relationship with cortisol and aldosteroneJ Sulon, F Sparano, F Sciarra, et al.

Clinical Endocrinology|May 1, 1978

Influence of hyperprolactinaemia due to metoclopramide on gonadal function in menP Falaschi, G Frajese, F Sciarra, et al.

Steroids|June 10, 1998

Hyperandrogenism in the adolescent femaleV Toscano, R Balducci, A Mangiantini, et al.

Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|January 19, 2000

Penile metastasis from carcinoma of the prostate in a patient with high serum prostate specific antigen levelsA Sciarra, G D'Eramo, P Casale, et al.

The Prostate|October 6, 1998

Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasiaF Di Silverio, S Monti, A Sciarra, et al.

BJU International|March 11, 2004

Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluationE De Berardinis, G Antonini, G J Peters, et al.

Pageof 15

Showing results (91-100 of 150) with videos related to

Sort By:

Pageof 15

Journal of Andrology|March 1, 1996

Ultrastructural and immunohistochemical characterization of the tunica albuginea in Peyronie's disease and veno-occlusive dysfunctionV Gentile, A Modesti, G La Pera, et al.

European Urology|January 1, 1997

Effects of short-term treatment with the alpha 1-blocker alfuzosin on urodynamic pressure/flow parameters in patients with benign prostatic hyperplasiaG Martorana, C Giberti, F Di Silverio, et al.

Minerva Medica|April 7, 1983

[Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension]C Tosti-Croce, R Mantellini, P Fanti, et al.

The Journal of Clinical Endocrinology and Metabolism|August 1, 1990

Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian diseaseV Toscano, R Balducci, P Bianchi, et al.

Clinical Endocrinology|May 1, 1978

24 hour profile of 18-hydroxy-11-deoxycorticosterone in normal supine man: relationship with cortisol and aldosteroneJ Sulon, F Sparano, F Sciarra, et al.

Clinical Endocrinology|May 1, 1978

Influence of hyperprolactinaemia due to metoclopramide on gonadal function in menP Falaschi, G Frajese, F Sciarra, et al.

Steroids|June 10, 1998

Hyperandrogenism in the adolescent femaleV Toscano, R Balducci, A Mangiantini, et al.

Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|January 19, 2000

Penile metastasis from carcinoma of the prostate in a patient with high serum prostate specific antigen levelsA Sciarra, G D'Eramo, P Casale, et al.

The Prostate|October 6, 1998

Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasiaF Di Silverio, S Monti, A Sciarra, et al.

BJU International|March 11, 2004

Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluationE De Berardinis, G Antonini, G J Peters, et al.

Pageof 15